Collectively, our data strongly support the notion that DDX24 is overexpressed in lung cancer and its elevated expression is associated with poor patient prognosis, implicating DDX24 as a potential driver of lung cancer progression. The gene discussed is DDX24; the disease is lung carcinoma.